Cargando…
Maternal Pharmacokinetics and Fetal Disposition of (±)-Citalopram during Mouse Pregnancy
[Image: see text] While selective-serotonin reuptake inhibitor (SSRI) antidepressants are commonly prescribed in the treatment of depression, their use during pregnancy leads to fetal drug exposures. According to recent reports, such exposures could affect fetal development and long-term offspring h...
Autores principales: | Velasquez, Juan C., Goeden, Nick, Herod, Skyla M., Bonnin, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2016
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384759/ https://www.ncbi.nlm.nih.gov/pubmed/26765210 http://dx.doi.org/10.1021/acschemneuro.5b00287 |
Ejemplares similares
-
Placental serotonin: implications for the developmental effects of SSRIs and maternal depression
por: Velasquez, Juan C., et al.
Publicado: (2013) -
A transient placental source of serotonin for the fetal forebrain
por: Bonnin, Alexandre, et al.
Publicado: (2011) -
Effects of prenatal exposure to (es)citalopram and maternal depression during pregnancy on DNA methylation and child neurodevelopment
por: Olstad, Emilie Willoch, et al.
Publicado: (2023) -
Application of a physiologically based pharmacokinetic model to predict isoniazid disposition during pregnancy
por: Amaeze, Ogochukwu U., et al.
Publicado: (2023) -
Development of Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Indomethacin Disposition in Pregnancy
por: Alqahtani, Saeed, et al.
Publicado: (2015)